Binge Eating Disorder | 18-55 | Outpatient | Up to $1,300
Segal Trials is currently conducting an outpatient clinical research study evaluating the safety and efficacy of an investigational medication for patients with Binge Eating Disorder
Participants may qualify if they are:
- Between the ages of 18-55
- Meets Binge Eating Disorder criteria
- Recurrent episodes of Binge Eating
- No Bariatric Surgery
- Cannot have participated in a weight loss program (3 months prior to screening)
- No Depression Episodes (3 months prior to screening)
- Study length: Up to 18 weeks
Participants who qualify may receive:
- Study-related exams & lab work – at no cost
- Available transportation
- No insurance is necessary
- Compensation up to $1,300 for time and Travel